Novabay Pharmaceuticals Inc (NBY) Live Share Price, Invest From India

Novabay Pharmaceuticals Inc Stock Performance

as on November 5, 2025 at 2:29 am IST

Day's Low
Day's High
$1.08
Day's Price Range
$1.14
$1.12
3.57%
Downside
1.79%
Upside
52 Week's Low
52 Week's High
$0.46
52-Week Price Range
$4.44
$1.12
58.93%
Downside
296.43%
Upside

Novabay Pharmaceuticals Inc share price movements today

Previous Close: $1.09
Open: $1.09
Volume: 648.2K
Day's Low - High: $1.08 - $1.14
52 Week Low - High: $0.46 - $4.44

Novabay Pharmaceuticals Inc Historical Returns

1 Month Return: -19.12 %
3 Month Return: + 80.04 %
1 Year Return: + 45.7 %
3 Year Return: -99.11 %
5 Year Return: -99.85 %

Novabay Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Novabay Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.6M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.47

Industry PE ratio

PEG Ratio

EBITDA

-5.6M

Revenue (TTM)

9.8M

Profit Margin

33.98%

Return On Equity TTM

-413.78%

Novabay Pharmaceuticals Inc Stock Valuation

Track how Novabay Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Novabay Pharmaceuticals Inc in the last 5 years

Overview
Trends

Lowest (-130.24x)

June 30, 2021

Industry (0.00x)

November 5, 2025

Today (0.47x)

November 5, 2025

Highest (-0.23x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.47x

Novabay Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novabay Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Novabay Pharmaceuticals Inc	BUY	$6.6M	-99.85%	0.47	33.98%
Insmed Incorporated	BUY	$39.0B	433.32%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$57.3B	207.17%	1446.9	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$109.2B	92.12%	30.3	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$67.5B	6.66%	15.38	32.13%

Stock Returns calculator for Novabay Pharmaceuticals Inc Stock including INR - Dollar returns

The Novabay Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Novabay Pharmaceuticals Inc investment value today

Current value as on today

₹1,53,016

Returns

₹53,016

(+53.02%)

Returns from Novabay Pharmaceuticals Inc Stock

₹47,368 (+47.37%)

Dollar Returns*

₹5,648 (+5.65%)

Analyst Recommendation on Novabay Pharmaceuticals Inc Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Novabay Pharmaceuticals Inc. Average target price of $0.85

Novabay Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Novabay Pharmaceuticals Inc.

What analysts predicted

-31.76%DOWNSIDE

Target Price

$0.85

Current Price

$1.12

Analyzed by

6 Analysts

Target

$0.85

Novabay Pharmaceuticals Inc target price $0.85, a slight downside of -31.76% compared to current price of $1.12. According to 6 analysts rating.

Novabay Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Novabay Pharmaceuticals Inc Stock has decreased by -85% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 6, 2025 to November 5, 2025

Change:-85% versus previous 30 day period

Novabay Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	4	3	3	2	2	2	2	2	-
Gross Profit	1	2	1	1	1	1	1	1	0	0
Operating Income	-1	-1	-1	0	-1	-1	-1	-1	-3	-1
EBITDA	-1	-1	-1	0	-3	-1	0	-	-3	-1
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-2	-1	-4	-3	-1	-2	-1	-3	-1
Income Tax Expense	0	0	0	0	0	-	-	-	0	-
Net Income	-1	-4	-1	-4	-3	-1	-1	-1	7	-1
Net Profit Margin	-55.67%	-87.46%	-53.98%	-110.22%	-122.16%	-66.04%	-49.65%	-52.49%	332.18%	0.00%

Novabay Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	4	11	18	12	6	9	8	14	10	9
Gross Profit	3	9	15	11	4	5	5	7	6	6
Operating Income	-21	-10	-7	-7	-9	-6	-8	-7	-5	-5
EBITDA	-20	-10	-7	-7	-9	-6	-8	-7	-4	-5
Interest Expense	-	-	-	-	1	0	3	3	1	0
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-18	-13	-7	-6	-9	-11	-5	-10	-9	-7
Income Tax Expense	0	0	0	0	0	0	-4	-3	0	-
Net Income	-18	-13	-7	-6	-10	-11	-6	-16	-9	-7
Net Profit Margin	-433.07%	-110.54%	-40.61%	-52.33%	-158.92%	-111.12%	-77.89%	-112.92%	-92.20%	-73.85%

Novabay Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	-1	-4	-3	-1	-1	-7	7	-1
Operating Cash Flow	-1	0	0	-1	0	-2	-5	-1	-2
Investing Cash Flow	0	0	0	1	0	0	1	-1	-
Financing Cash Flow	2	0	0	0	0	2	1	-1	0
Change in Cash	0	0	0	-1	-1	0	-2	8	-3

Novabay Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-13	-7	-6	-9	-11	-5	-10	-9	-7
Operating Cash Flow	-12	-6	-5	-7	-4	-9	-6	-4	-5
Investing Cash Flow	0	0	0	0	0	-12	0	0	1
Financing Cash Flow	19	0	5	11	9	16	4	1	1
Change in Cash	7	-6	0	3	5	-4	-2	-2	-2

Insights on Novabay Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 168.7% return, outperforming this stock by 124.3%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 923.2% return, outperforming this stock by 1022.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 7.67M → -1.92M (in $), with an average decrease of 125.1% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.44M → 2.30M (in $), with an average decrease of 2.7% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, NBY stock has moved down by -9.2%

About Novabay Pharmaceuticals Inc

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Organisation	Novabay Pharmaceuticals Inc
Headquarters	2000 Powell Street, Emeryville, CA, United States, 94608
Industry	Health Technology
CEO	Mr. Tommy Law
E-voting on shares	Click here to vote

Key Management of Novabay Pharmaceuticals Inc

Name	Title
Mr. Tommy Law	Controller, Interim CFO & Treasurer
Mr. Justin M. Hall Esq., J.D.	VP of Business Dev., General Counsel, Chief Compliance Officer, Corporate Secretary & Director

FAQs

What is Novabay Pharmaceuticals Inc share price today?

Novabay Pharmaceuticals Inc share price today is $1.12 as on November 5, 2025 at 2:29 am IST at the close of the market. Novabay Pharmaceuticals Inc share today touched a day high of $1.14 and a low of $1.08.

What is the 52 week high and 52 week low for Novabay Pharmaceuticals Inc share?

Novabay Pharmaceuticals Inc share touched a 52 week high of $4.44 on September 4, 2025 and a 52 week low of $0.46 on April 8, 2025. Novabay Pharmaceuticals Inc stock price today i.e. November 5, 2025 at 2:29 am IST is closed at $1.12,which is 74.77% down from its 52 week high and 143.48% up from its 52 week low.

What is Novabay Pharmaceuticals Inc's market capitalisation today?

Novabay Pharmaceuticals Inc market capitalisation is $0.00T as on November 5, 2025 at 2:29 am IST.

How to invest in Novabay Pharmaceuticals Inc Stock (NBY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Novabay Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novabay Pharmaceuticals Inc Shares that will get you 1.3393 shares as per Novabay Pharmaceuticals Inc share price of $1.12 per share as on November 5, 2025 at 2:29 am IST.

What is the minimum amount required to buy Novabay Pharmaceuticals Inc Stock (NBY) from India?

Indian investors can start investing in Novabay Pharmaceuticals Inc (NBY) shares with as little as ₹88.67 or $1 (as of November 5, 2025 at 9:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.70 in Novabay Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on November 5, 2025 at 9:44 am IST). Based on Novabay Pharmaceuticals Inc share’s latest price of $1.12 as on November 5, 2025 at 2:29 am IST, you will get 8.9286 shares of Novabay Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Novabay Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Novabay Pharmaceuticals Inc stock has given -99.85% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?